Treatment with Cardiotonic Pills® after Ischemia-Reperfusion Ameliorates Myocardial Fibrosis in Rats

Microcirculation

Volumn 20, Issue 1, 2013, Pages 17-29

  Wei, Xiao Hong ^b   Liu, Yu Ying ^b   Li, Quan ^b   Yan, Li ^b   Hu, Bai He ^b   Pan, Chun Shui ^b   Li, Zhi Xin ^b   Chang, Xin ^b   Fan, Jing Yu ^b   Zhao, Na ^b   Sun, Kai ^b   Huang, Ping ^b   Wang, Chuan She ^b   Fan, Tai Ping ^c   Han, Jing Yan ^a,b,d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b State Administration of Traditional Chinese Medicine   (China)

^c TRINITY COLLEGE   (United Kingdom)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cardiac microcirculation; Chemokines; Leukocytes; Myocardial infarction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARDIOTONIC AGENT; CD68 ANTIGEN; COLLAGEN; GELATINASE B; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEART DISEASE; HEART FUNCTION; HEART FUNCTION TEST; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; MALE; MONOCYTE; NONHUMAN; PILL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ACTINS; ANIMALS; BORNANES; CARDIOTONIC AGENTS; CHEMOKINE CCL2; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FIBROSIS; HEMODYNAMICS; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 9; MICROCIRCULATION; MICROSCOPY, ELECTRON, TRANSMISSION; MONOCYTES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PANAX NOTOGINSENG; PEROXIDASE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

RATTUS;

EID: 84872259030     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12002     Document Type: Article

References (36)

1. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356: 1503-1516, 2007.
2. Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74: 184-195, 2007.
3. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 53: 585-595, 2004.
4. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 97: 738-747, 2007.
5. Geng J, Peng W, Huang Y, Fan H, Li S. Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats. Eur J Pharmacol 634: 162-169, 2010.
6. Guo J, Sun K, Wang CS, Fang SP, Horie Y, Yang JY, Liu YY, Wang F, Liu LY, Fan JY, Hibi T, Han JY. Protective effects of dihydroxylphenyl lactic acid and salvianolic acid B on LPS-induced mesenteric microcirculatory disturbance in rats. Shock 29: 205-211, 2008.
7. Han JY, Horie Y, Fan JY, Sun K, Guo J, Miura S, Hibi T. Potential of 3, 4-dihydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-induced microvascular disturbance in rat mesentery. Am J Physiol Gastrointest Liver Physiol 296: G36-G44, 2009.
8. Han JY, Miura S, Akiba Y, Higuchi H, Kato S, Suzuki H, Yokoyama H, Ishii H. Chronic ethanol consumption exacerbates microcirculatory damage in rat mesentery after reperfusion. Am J Physiol Gastrointest Liver Physiol 280: G939-G948, 2001.
9. Hishikari K, Suzuki J, Ogawa M, Isobe K, Takahashi T, Onishi M, Takayama K, Isobe M. Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. Cardiovasc Res 81: 123-132, 2009.
10. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 81: 457-464, 2009.
11. Horino K, Nishiura H, Ohsako T, Shibuya Y, Hiraoka T, Kitamura N, Yamamoto T. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest 78: 603-617, 1998.
12. Jia Y, Huang F, Zhang S, Leung SW. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol 157: 330-340, 2011. [Epub ahead of print].
13. Kakkar AK, Lefer DJ. Leukocyte and endothelial adhesion molecule studies in knockout mice. Curr Opin Pharmacol 4: 154-158, 2004.
14. Kohno T, Anzai T, Naito K, Sugano Y, Maekawa Y, Takahashi T, Yoshikawa T, Ogawa S. Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. Circ J 72: 1685-1692, 2008.
15. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 74: 207-212, 2007.
16. Li XY, Xu L, Lin GS, Jiang XJ, Wang T, Lu JJ, Zeng B. Protective effect of caffeine administration on myocardial ischemia/reperfusion injury in rats. Shock 36: 289-294, 2011.
17. Lin YL, Wu CH, Luo MH, Huang YJ, Wang CN, Shiao MS, Huang YT. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol 105: 215-222, 2006.
18. Lu T, Yang J, Gao X, Chen P, Du F, Sun Y, Wang F, Xu F, Shang H, Huang Y, Wang Y, Wan R, Liu C, Zhang B, Li C. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos 36: 1578-1586, 2008.
19. Lv Z, Song Y, Xue D, Zhang W, Cheng Y, Xu L. Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-beta1 in activated rat hepatic stellate cells. J Ethnopharmacol 132: 384-392, 2010.
20. Nishiura H, Shibuya Y, Matsubara S, Tanase S, Kambara T, Yamamoto T. Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein. J Biol Chem 271: 878-882, 1996.
21. Oda Y, Tokita K, Ota Y, Li Y, Taniguchi K, Nishino N, Takagi K, Yamamoto T, Nishiura H. Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J Biochem 144: 371-381, 2008.
22. Ojha N, Roy S, Radtke J, Simonetti O, Gnyawali S, Zweier JL, Kuppusamy P, Sen CK. Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 294: H2435-H2443, 2008.
23. Park WH, Lee SK, Kim CH. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats. Life Sci 76: 1675-1690, 2005.
24. Ren G, Dewald O, Frangogiannis NG. Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy 2: 242-256, 2003.
25. Roy S, Khanna S, Kuhn DE, Rink C, Williams WT, Zweier JL, Sen CK. Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics 25: 364-374, 2006.
26. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74: 196-206, 2007.
27. Shi L, Tsurusaki S, Futa N, Sakamoto T, Matsuda T, Nishino N, Kunitomo R, Kawasuji M, Tokita K, Yamamoto T. Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion. Virchows Arch 447: 747-755, 2005.
28. Stawowy P, Margeta C, Kallisch H, Seidah NG, Chretien M, Fleck E, Graf K. Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase. Cardiovasc Res 63: 87-97, 2004.
29. Sun K, Wang CS, Guo J, Horie Y, Fang SP, Wang F, Liu YY, Liu LY, Yang JY, Fan JY, Han JY. Protective effects of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Life Sci 81: 509-518, 2007.
30. Wang G, Wang L, Xiong ZY, Mao B, Li TQ. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. Med Sci Monit 12: SR1-SR7, 2006.
31. Wang YH, Xu F, Chen J, Shen X, Deng YP, Xu LL, Yin J, Chen H, Teng FK, Liu X, Wu WY, Jiang BH, Guo DA. Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: inhibition by salvianolic acid B from Salvia miltiorrhiza. Phytomedicine 19: 13-19, 2011.
32. Xia Y, Lee K, Li N, Corbett D, Mendoza L, Frangogiannis NG. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol 131: 471-481, 2009.
33. Xu XS, Ma ZZ, Wang F, Hu BH, Wang CS, Liu YY, Zhao XR, An LH, Chang X, Liao FL, Fan JY, Niimi H, Han JY. The antioxidant Cerebralcare Granule attenuates cerebral microcirculatory disturbance during ischemia-reperfusion injury. Shock 32: 201-209, 2009.
34. Yuan Q, Liu YY, Sun K, Chen CH, Zhou CM, Wang CS, Li A, Zhang SW, Ye ZL, Fan JY, Han JY. Improving effect of pretreatment with yiqifumai on LPS-induced microcirculatory disturbance in rat mesentery. Shock 32: 310-316, 2009.
35. Yue QX, Xie FB, Song XY, Wu WY, Jiang BH, Guan SH, Yang M, Liu X, Guo DA. Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury. J Ethnopharmacol 141: 659-667, 2011. [Epub ahead of print].
36. Zhao N, Liu YY, Wang F, Hu BH, Sun K, Chang X, Pan CS, Fan JY, Wei XH, Li X, Wang CS, Guo ZX, Han JY. Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. Am J Physiol Heart Circ Physiol 298: H1166-H1176, 2010.